Novel Anti-infectives Drug Development
An increasing number of illnesses are becoming life-threatening as they evolve resistance to antibiotics that work by killing the bacteria or stopping their growth. Any bacteria resistant to these drugs have an evolutionary advantage enabling them to thrive, spread and become more dangerous. Without a fundamentally different paradigm for first line control of infectious disease, medically important antibiotics may become useless within decades.
Quellthera is harnessing the biologic foundations of plant immunity as an effective new concept in treatment of infectious disease. Novel molecular complexes based on natural polyphenols bind to toxins and cell signals that control bacterial behavior while resetting the body’s immune response – without negative side effects or destruction of the microbiome.